Edit
Aptiv Solutions
http://www.aptivsolutions.com/Last activity: 03.11.2014
Probably Closed - Reference to ICON Specialty Labs (formerly MolecularMD)
Aptiv Solutions is a global biopharmaceutical and medical device development services company focused on recognizing, understanding and enabling clients to capitalize on rapid and fundamental changes facing companies developing products in the pharmaceutical, biotech and medical device market. The Company offers its clients an extensive portfolio of services including adaptive clinical trials, early phase product strategy, regulatory services, pharmacovigilance, clinical staffing and the operational support of a global clinical research organization. Aptiv has over 700 professionals in North America, Europe, the Middle East, Japan, and Australia, and operates out of 22 offices in 17 countries.
Location: United States, Virginia, Reston
Investors 1
| Date | Name | Website |
| - | The Halifa... | thehalifax... |
Mentions in press and media 11
| Date | Title | Description |
| 03.11.2014 | Personalized medicine player Theranostics has new CEO, raising $1M | More from MedCity News on Theranostics here. Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficiently during uncertain times. SAP Promoted Telemedicine’s potential to provide healthcare to the wor... |
| 02.05.2014 | Hospitals may have to publish their prices | MassDevice.com On Call | MASSDEVICE ON CALL — U.S. Medicare regulators want hospitals to open up about the prices they charge for their services. The agency issued a proposed order to require hospitals to publish price-lists, or make them available upon request. Th... |
| 28.02.2014 | Still in the renal denervation space? Startups, consider adaptive trial design, CRO says | For instance, if a sub-population of patients seems to respond with much more efficacious outcomes than the whole population early on, the trial can be adjusted to focus just on those patients. For startups, Dentry-Mabry said, it can be att... |
| 04.04.2013 | Larger U.S. patients means larger medical devices | MassDevice.com On Call | MASSDEVICE ON CALL — Makers of durable medical equipment have had to shift their manufacturing parameters in recent years in order to accommodate the ever-growing rates of obesity in the U.S. It’s sometimes a "heartbreaking" situa... |
| 02.04.2013 | Ex-SurModics CEO Ankeny starts as new Minnetronix CFO | Personnel Moves | New Minnetronix CFO started yesterday The new CFO of Minnetronix, Phil Ankeny, joined the company today. Ankeny moved over to Minnetronix from SurModics Inc., where he served as interim CEO and CFO. His background is in venture capital, IT ... |
| 11.04.2012 | The Med-Tech Mid-Summer Classic: MassDevice Big 100 Roundtable East | MassDevice.com is proud to announce an exceptional lineup of medical device leaders for the MassDevice Big 100 Regional Roundtable East on July 10, 2012, in Waltham, Mass. The Big 100 Roundtable is a conversation among leaders – an unforget... |
| 14.04.2011 | Clinical Research firm Trio rebrands, changes strategy after merger | The North Carolina CRO that launched as Trio Clinical Research is moving forward with a new name and a different strategy. Trio changed its official name to Trio Clinical Resourcing, a change that reflects the Raleigh, N.C.-based CRO’s focu... |
| 13.04.2011 | Raleigh CRO Trio changes name, strategy as part of Aptiv Solutions | Promoted This Patient Experience Checklist Is Your Key To Success in 2021 As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
| - | Raleigh CRO Trio changes name, strategy as part of Aptiv Solutions | The North Carolina CRO that launched as Trio Clinical Research is moving forward with a new name and a different strategy. Trio has changed its official name to Trio Clinical Resourcing, a change that reflects the Raleigh, North Carolina CR... |
| - | Personalized medicine player Theranostics has new CEO, raising $1M | Personalized medicine player Theranostics is in the midst of a modest fund raise – it’s raising $1 million in equity, according to a regulatory filing. Not to be confused with biotech media darling Theranos – the Bay Area startup that means... |
Show more